Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Affymetrix Confidential
Application of Automated RNA in situ Hybridisation in Routine Clinical Practice: Targeting Albumin, Kappa/Lambda and High Risk HPV
Biomarker Meeting, Munich, Dec 2015
Paul Turner, PhD
Affymetrix Confidential
2
ViewRNA ISH: Dopamine Receptor D1A (Drd1a)
Affymetrix Confidential
3
Examples ISH IHC View RNA ISH (red) IHC (green): Rat Testes Automated
Affymetrix Confidential
4
ViewRNA Assays
Permeabilize cells and unmask RNA RNA-1
RNA-2
1. Pretreat: FFPE/Frozen tissue sections are pretreated to allow access to target RNA
2. Hybridize: Gene specific “II” (double I) probe pairs and blocking probes hybridize to target RNA
3. Amplify: A signal amplification tree is created with a series of sequential hybridization steps or PreAmp, Amp and Labeled Probes
4. Detect: Target RNA is detected chromogenically or fluorescently and visualized with a brightfield or fluorescent microscope
Affymetrix Confidential
5
ViewRNA ISH 2-plex ISH detection in dog kidneys
Data provided courtesy of customer. Target identifications not disclosed.
Affymetrix Confidential
6
RNA ISH Workflow –Automated
Affymetrix Confidential
7
RNA ISH in the Clinical Laboratory
3 RNA Biomarker Assays
• Albumin
• Kappa/Lambda immunoglobulin light chains
• High Risk Human Papilloma Virus (HPV)
Affymetrix Confidential
8
Affymetrix Confidential
9
Markers of Hepatocellular Carcinoma
Sensitivity (all grades)
Sensitivity (poorly differentiated)
Specificity
Albumin ISH 99% 99% Excellent
Arginase 84% 71% Excellent
HepPar1 83% 64% Poor
Shahid M, Mubeen A, Tse J, Kakar S, Bateman AC, Borger D, Rivera MN, Ting DT, Deshpande V. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms. Am J Surg Pathol. 2015 Jan;39(1):25-34.
Affymetrix Confidential
10
Liver Carcinoma
Hepatocellular Carcinoma
Intrahepatic Cholangiocarcinoma
Affymetrix Confidential
11
Affymetrix Confidential
12
Liver primary
Metastasis
Cholangiocarcioma Metastatic carcinoma
Hepatic resection
Chemotherapy
Management of Primary and Secondary Liver Cancers
Affymetrix Confidential
13
Albumin ISH
• 66 of 69 IHCCs (96%) positive for albumin expression
• 8 of 8 well-differentiated (100%)
• 41 of 43 moderately-differentiated (95%)
• 17 of 18 poorly-differentiated (94%)
• 42 of 42 HCCs (100%) were positive for albumin expression
• 0 of 351 non-hepatic carcinomas were positive for albumin expression • Group included adenocarcinomas from lung (N =22), esophagus (N =40),
stomach (N =72), colon (N =40), gallbladder (N=10), pancreas (N =95), urogenital tract (N=8), ovary (N=8), and endometrium (N=8)
• Additionally, 22 carcinomas metastatic to the liver from known primary tumors of the colon, breast and lung were evaluated
Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ann Surg Oncol. 2014 Dec 18.
Affymetrix Confidential
14
Albumin in the Clinical Laboratory
• 44/M
• Liver transplant
• 7 cm mass in the liver
• ?PET avid lesion in small bowel
• Clinical impression- Metastatic carcinoma!
Affymetrix Confidential
15
H&E Albumin ISH
Intrahepatic Cholangiocarcinoma
Affymetrix Confidential
16
• Lymphoma = Cancer clone of Lymphocytes
• Lymphocytes are either Kappa or Lambda
• Current ISH assay can ONLY detect signal in plasma cells
2. ISH for Kappa (IGKC) and Lambda (IGLC) for the Diagnosis of Lymphoma
Affymetrix Confidential
17
Normal Lymphocytes
Kappa
Lambda
Affymetrix Confidential
18
Kappa Lymphoma (malignant)
Kappa
Lambda
Affymetrix Confidential
19
Lambda Lymphoma (malignant)
Kappa
Lambda
Affymetrix Confidential
20
Type 1 Kappa Type 6 Lambda
Normal Reactive Lymph Node
?
Affymetrix Confidential
21
Type 1 Kappa Type 6 Lambda
Lymphoma Kappa clonal
?
Affymetrix Confidential
22
Kappa Lambda
Vocal Cord Automated
Affymetrix Confidential
23
Lamda Positive: Automated
Affymetrix Confidential
24
Interpretive Algorithm for K/L ISH
Probe Design
IGLL-5
IGLC
IGLC probe = IGLC+IGLL-5
Kshitij Arora, Ivan Chebib, Lawrence Zukerberg, Manoj Gandhi, Miguel Rivera, David Ting, Vikram Deshpande. Branched-Chain in situ Hybridization for κ and λ Light Chains: A Powerful Ancillary Technique for Determining B-Cell Clonality in Cytology Samples. Cancer Cytopathology. 2015 Aug 31.
Affymetrix Confidential
25
3. High Risk (HR) HPV detection in HNSCC
• HR-HPV present in subset of primary HNSCC (mainly non-keratinizing SCC)
• p16 IHC positivity not indicative of transcriptionally active HPV (HR)
• IHC followed by PCR or DNA ISH
• HR-HPV - 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, & 68
• HPV16 – ~90%, • HPV18 – ~ 5% • HPV33 – ~ 2%
• Low risk HPV – 6, 11 (not as important)
• RNA ISH allows determination of the variant of HPV, which is important for patient eligibility towards clinical trials
Affymetrix Confidential
HPV16 – E6/E7 RNA ISH
ViewRNA Manual ISH 2-plex assay HPV16 – Fast Red Keratin 7 – Fast Blue
Affymetrix Confidential
27
HPV 16 TMA Head and Neck Cancer
Affymetrix Confidential
28
HPV 16 TMA Head and Neck Cancer
Affymetrix Confidential
29
Darcy A. Kerr, Kshitij S. Arora, Krishnan K. Mahadevan, Jason L. Hornick, Jeffrey F. Krane, Miguel N. Rivera, David T. Ting, Vikram Deshpande, William C. Faquin. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma. Am J Surg Pathol. Dec 2105.
Sensitivity of RNA ISH vs DNA ISH for hr HPV
Affymetrix Confidential
30
ViewRNA™: Integration of gene expression and morphology
Traditional pathology (H&E)
• Cell type and tissue
structure
• No molecular information
Traditional molecular pathology (IHC)
• Cell type and tissue structure
• Limited by antibody availability & quality
Traditional molecular assays (bind and grind)
• Quantitative assays
• Lack cellular resolution
ViewRNA Assays Molecular Detection and Morphological Context
Molecular detection for any target gene
Morphological context of gene expression
Amenable to Quantitation